The relaxant activity of 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-trioxide in the mouse corpus cavernosum

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 2, 2006, Pages 753-761

  Göçmen, Cemil ^a   Büyüknacar, H Sinem ^a   Ya Kots, Alexander ^b   Murad, Ferid ^b   Kiroǧlu, Olcay ^a   Kumcu, Eda Karabal ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4,7 DIMETHYL 1,2,5 OXADIAZOLO[3,4 D]PYRIDAZINE 1,5,6 TRIOXIDE; ALKYLATING AGENT; CYSTEINE; DIAMIDE; DITHIOTHREITOL; GLUTATHIONE; GUANYLATE CYCLASE; GUANYLATE CYCLASE ACTIVATOR; GUANYLATE CYCLASE INHIBITOR; N ETHYLMALEIMIDE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG ACTIVITY; ELECTROSTIMULATION; ENZYME ACTIVATION; ENZYME PURIFICATION; MALE; MOUSE; NONHUMAN; POLAROGRAPHY; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CYCLIC N-OXIDES; ELECTRIC STIMULATION; GUANYLATE CYCLASE; MALE; MICE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE DONORS; PENIS; PYRIDAZINES; SULFHYDRYL COMPOUNDS;

EID: 31144450688     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.094250     Document Type: Article

References (33)

1. Aleryani S, Milo E, and Kostka P (1999) Formation of peroxynitrite during thiolmediated reduction of sodium nitroprusside. Biochim Biophys Acta 1472:181-190.
2. Brooker G, Harper JF, Terasaki WL, and Moylan RD (1979) Radioimmunoassay of cyclic AMP and cyclic GMP. Adv Cyclic Nucleotide Res 10:1-33.
3. Burnett AL, Nelson RJ, Calvin DC, Liu JX, Demas GE, Klein SL, Kriegsfeld LJ, Dawson VL, Dawson TM, and Snyder SH (1996) Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase. Mol Med 2:288-296.
4. Calvino R, Fruttero R, Ghigo D, Bosia A, Pescarmona GP, and Gasco A (1992) 4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation. J Med Chem 35:3296-3300.
5. Campbell DL, Stamler JS, and Strauss HC (1996) Redox modulation of L-type calcium channels in ferret ventricular myocytes: dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 108:277-293.
6. Cellek S and Moncada S (1997) Nitrergic control of peripheral sympathetic responses in the human corpus cavernosum: a comparison with other species. Proc Natl Acad Sci USA 94:8226-8231.
7. Ellis A, Li CG, and Rand MJ (2000) Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta. Br J Pharmacol 129:315-322.
8. Feelisch M, Schonafinger K, and Noak E (1992) Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans. Biochem Pharmacol 44: 1149-1157.
9. Ferioli R, Folco GC, Ferretti C, Gasco AM, Medana C, Fruttero R, Civelli M, and Gasco A (1995) A new class of furoxan derivativates as nitric oxide donors: mechanism of action and biological activity. Br J Pharmacol 114:816-820.
10. Friebe A and Koesling D (1998) Mechanism of YC-1 induced activation of soluble guanylyl cyclase. Mol Pharmacol 53:123-127.
11. Garcia-Pascual A, Costa G, Labadia A, Jimenez E, and Triguero D (1999) Differential mechanisms of urethral smooth muscle relaxation by several NO donors and nitric oxide. Naunyn-Schmiedeberg's Arch Pharmacol 360:80-91.
12. Garcia-Pascual A, Labadia A, Costa G, and Triguero D (2000) Effects of superoxide anion generators and thiol modulators on nitrergic transmission and relaxation to exogenous nitric oxide in the sheep urethra. Br J Pharmacol 129:53-62.
13. Gillespie JS and Sheng H (1990) The effects of pyrogallol and hydroquinone on the response to NANC nerve stimulation in the rat anococcygeus and the bovine retractor penis muscles. Br J Pharmacol 99:194-196.
14. Göçmen C, Uçar P, S, ingirik E, Dikmen A, and Baysal F (1997) An in vitro study of nonadrenergic-noncholinergic activity on the cavernous tissue of mouse. Urol Res 25:269-275.
15. Göçmen C, Seçilmis, A,Uçar P, Karatas, Y, Önder S, Dikmen A, and Baysal F (1998) A possible role of S-nitrosothiols at the nitrergic relaxations in the mouse corpus cavernosum. Eur J Pharmacol 361:85-92.
16. Ignarro LJ (1989) Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters. Pharm Res (NY) 6:651-659.
17. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, and Gruetter CA (1981) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218:739-749.
18. Kalsi JS, Rees RW, Hobbs AJ, Royle M, Kell PD, Ralph DJ, Moncada S, and Cellek S (2003) BAY41-2272, a novel nitric oxide-independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro. J Urol 169:761-766.
19. Kasakov L, Cellek S, and Moncada S (1995) Characterization of nitrergic neurotransmission during short- and long-term electrical stimulation of the rabbit anococcygeus muscle. Br J Pharmacol 115:1149-1154.
20. Kots AY, Grafov MA, Khropov YV, Betin VL, Belushkina NN, Busygina OG, Yazykova MY, Ovchinnikov IV, Kulikov AS, Makhova NN, et al. (2000) Vasorelaxant and antiplatelet activity of 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d] pyridazine 1,5,6-trioxide: role of soluble guanylate cyclase, nitric oxide and thiols. Brit J Pharmacol 129:1163-1177.
21. Li CG and Rand MJ (1989) Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle. Clin Exp Pharmacol Physiol 16:933-938.
22. Martin E, Sharina I, Kots AY, and Murad F (2003) A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation. Proc Natl Acad Sci USA 100:9208-9213.
23. Mateo AO and de Artinano AA (2000) Nitric oxide reactivity and mechanisms involved in its biological effects. Pharmacol Res 42:421-427.
24. Medana C, Ermondi G, Fruttero R, Di Stilo A, Ferretti C, and Gasco A (1994) Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation. J Med Chem 37:4412-4416.
25. Murphy ME, Piper HM, Watanabe H, and Sies H (1991) Nitric oxide production by cultured aortic endothelial cells in response to thiol depletion and replenishment. J Biol Chem 266:19378-19383.
26. Pataricza J, Penke B, Balogh GE, and Papp JG (1998) Polarographic detection of nitric oxide released from cardiovascular compounds in aqueous solutions. J Pharmacol Toxicol Methods 39:91-95.
27. Rajanayagam MAS, Li CG, and Rand MJ (1993) Differential effects of hydroxocobalamin on NO-mediated relaxations in rat aorta and anococcygeus muscle. Br J Pharmacol 108:3-5.
28. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, and Ignarro LJ (1992) Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 326:90-94.
29. Resim S, Büyüknacar HSG, Göçmen C, Önder S, and Dikmen A (2002) A possible role of sulphydryl reagents on the tonic activity of the rat detrusor muscle. Eur J Pharmacol 442:295-299.
30. Saenz de Tejada I (1992) Nitric oxide as a mediator of relaxation of the corpus cavernosum. N Engl J Med 326:1638.
31. Saenz de Tejada I (2004) Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat. Int J Impot Res 16:S40-S42.
32. Sezen SF and Burnett AL (2000) Intracavernosal pressure monitoring in mice: responses to electrical stimulation of the cavernous nerve and to intracavernosal drug administration. J Androl 21:311-315.
33. Wanstall JC, Jeffery TK, Gambino A, Lovren F, and Triggle CR (2001) Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion. Br J Pharmacol 134:463-472.